Testosterone deficiency is associated with increased pro-inflammatory cytokines, and testosterone supplementation has been shown to reduce anti-inflammatory cytokines (IL-10) and pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) in patients with coronary artery disease, prostate cancer and diabetes [67]. This evidence concerns the gene IL6 and prostate cancer.